Baseline characteristics | |
n | 83 |
Age (years) | 53.0 [40.5/67.0] |
Gender (m/f) | 57/26 [68.7%/31.3%] |
BMI (kg/m2) | 27.1 [23.4/29.9] |
ICU length of stay (days) | 28.0 [20.0/42.0] |
Time of first awakening (days after admission) | 12.0 [9.0/20.0] |
Survival (non-survivors/survivors) | 14/69 [16.9%/83.1%] |
Catastrophic event leading to ICU admission | |
ARDS | 28 [33.7%] |
Sepsis | 20 [24.1%] |
Trauma | 19 [22.9%] |
CNS | 15 [18.1%] |
Miscellaneous | 1 [1.2%] |
Illness severity at ICU admission | |
SOFA score | 13 [10/15] |
APACHE | 23 [17/28] |
SAPS2 | 52 [39/63] |
Time interval between ICU admission and muscle biopsy | |
N | 59 |
Biopsy day (days after admission) | 16.0 [14.0/19.5] |
RASS | -3.0 [-4.0/-1.0] |
Percent of days with RASS > − 3 | 40.0 [22.3/64.6] |
Noradrenalin (µg/kg*min) | 0.05 [0.03/0.10] |
Noradrenalin days (days noradrenalin was required to maintain blood pressure) | 9.0 [5.0/12.0] |
Percent of days with septic shock (%) | 21.4 [8.6/43.6] |
Intervention quantity | |
Net time patient received physiotherapy per day until muscle biopsy (minutes)a | 18.2 [13.3/21.7] |
Net time patient received physiotherapy per day until ICU discharge (minutes)a | 20.0 [14.2/22.8] |
Healthy controls—plasma | |
n | 91 |
Age (years) | 53.0 [42.0/66.5] |
Gender (m/f) | 51/40 [56.0%/44.0%] |
Healthy controls—muscle biopsy specimen | |
n | 11 |
Age (years) | 58.0 [44.0/56.0] |
Gender (m/f) | 7/4 [63.6%/36.4%] |